|
|
|
Insider
Information: |
Fenton Dennis M |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
84,394 |
|
Indirect Shares
|
118,518 |
|
|
Direct
Value |
$1,976,195 |
|
|
Indirect Value
|
$35,125,180 |
|
|
Total
Shares |
202,912 |
|
|
Total
Value |
$37,101,375 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amgen Inc |
AMGN |
Executive V.P., Operat... |
2007-06-04 |
6,668 |
2007-06-04 |
118,518 |
Premium* |
|
Genzyme Corp |
GENZ |
Director |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
Xenoport Inc |
XNPT |
Director |
2016-07-05 |
0 |
2016-07-05 |
0 |
Premium* |
|
Dendreon Corp |
DNDN |
Director |
2014-01-03 |
75,000 |
2012-01-03 |
0 |
Premium* |
|
Kythera Biopharmaceuticals Inc |
KYTH |
Director |
2012-10-16 |
1,476 |
2015-10-01 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2016-06-17 |
0 |
Premium* |
|
Sienna Biopharmaceuticals, Inc. |
SNNA |
Director |
2017-09-18 |
1,250 |
2017-09-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
102 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 5
|
102 Records found
|
|
Page 5 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|